Joel K. Caldwell

All filings by Joel K. Caldwell on record concern Cytrx Corp. In total, 2 filings cover trades dated 7 August 2020.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 13 August 2020, reports an option exercise of €99k in Cytrx Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.